Advances in Translational Research and Clinical Care in Pancreatic Cancer: Where Are We Headed?
While significant advances have been made in the treatment of many different solid tumors, pancreatic cancer remains a glaring exception. Overall 5-year survival rates for pancreatic cancer remain in the single digits. While newer chemotherapy regimens such as FOLFIRINOX and nab-paclitaxel/gemcitabi...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2019-01-01
|
| סדרה: | Gastroenterology Research and Practice |
| גישה מקוונת: | http://dx.doi.org/10.1155/2019/7690528 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|